These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19187864)

  • 61. [Infection by hepatitis virus among the indigenous populations of South America: a review of the problem].
    Echevarría JM; Blitz-Dorfman L; Pujot FH
    Invest Clin; 1996 Sep; 37(3):191-200. PubMed ID: 8983357
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    Dong Y; Liu SL; Zhai XJ; Zhu FC; Pan H; Yu JX; Chen YZ; Xie YR; Zhang XY; Zhang HM; Li LJ; Wang H; Ruan B
    J Med Virol; 2009 Sep; 81(9):1517-24. PubMed ID: 19626618
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of hepatitis B and C: a Jinnah Postgraduate Medical Centre experience.
    Sami S; Korejo R; Bhutta SZ
    J Obstet Gynaecol Res; 2009 Jun; 35(3):533-8. PubMed ID: 19527395
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Review article: vaccination and viral hepatitis - current status and future prospects.
    Koff RS
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1285-92. PubMed ID: 17868433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The epidemiology of non-A, non-B hepatitis (NANB). A review of the literature].
    Pellicanò S; Foti N
    Minerva Med; 1990 Mar; 81(3):157-68. PubMed ID: 2108397
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Epidemiology of viral hepatitis cases, types B and C, transmitted from carriers--health service workers to patients. Is it still a"no problem" issue in Poland].
    Bilski B; Wysocki J
    Med Pr; 2005; 56(6):491-4. PubMed ID: 16613375
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Decrease of dual hepatitis B and C virus infections in children with cancer: changes in risk factors over 30 years.
    Koltan S; Styczynski J; Wysocki M; Koltan A; Kurylak A; Debski R
    Haematologica; 2004 Feb; 89(2):251-2. PubMed ID: 15003909
    [No Abstract]   [Full Text] [Related]  

  • 68. [Hepatitis B vaccine in patients with human immunodeficiency virus infection].
    Ramírez O CA; Fernández A DG; Valderrama B SL; Gómez Q CH; Támara R JR; Alvarez M CA
    Rev Chilena Infectol; 2009 Feb; 26(1):26-33. PubMed ID: 19350156
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
    Romanò L; Paladini S; Tagliacarne C; Zappa A; Zanetti AR
    Vaccine; 2009 May; 27(25-26):3439-42. PubMed ID: 19200848
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Variation in interpretation and counselling of blood exposure incidents by different medical practitioners.
    van Wijk PT; Pelk-Jongen M; Wijkmans C; Voss A; Timen A; Schneeberger PM
    Am J Infect Control; 2008 Mar; 36(2):123-8. PubMed ID: 18313514
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular detection of hepatitis B, hepatitis C, and torque teno viruses in drug users in Saudi Arabia.
    Alzahrani AJ; Dela Cruz DM; Obeid OE; Bukhari HA; Al-Qahtani AA; Al-Ahdal MN
    J Med Virol; 2009 Aug; 81(8):1343-7. PubMed ID: 19551834
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Strategies to prevent and control hepatitis B and C virus infections: a global perspective.
    Mast EE; Alter MJ; Margolis HS
    Vaccine; 1999 Mar; 17(13-14):1730-3. PubMed ID: 10194830
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Scope of worldwide hepatitis C problem.
    Brown RS; Gaglio PJ
    Liver Transpl; 2003 Nov; 9(11):S10-3. PubMed ID: 14586889
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevalence of hepatitis 'B' and 'C' in orthopaedics patients at Ayub Teaching Hospital Abbottabad.
    Khan MS; Jamil M; Jan S; Zardad S; Sultan S; Sahibzada AS
    J Ayub Med Coll Abbottabad; 2007; 19(4):82-4. PubMed ID: 18693606
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology.
    Hendrickx G; Van Herck K; Vorsters A; Wiersma S; Shapiro C; Andrus JK; Ropero AM; Shouval D; Ward W; Van Damme P
    J Viral Hepat; 2008 Oct; 15 Suppl 2():1-15. PubMed ID: 18837827
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hepatitis B virus infection in dentistry: a forgotten topic.
    Mahboobi N; Agha-Hosseini F; Mahboobi N; Safari S; Lavanchy D; Alavian SM
    J Viral Hepat; 2010 May; 17(5):307-16. PubMed ID: 20196802
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute hepatitis C in Israel: a predominantly iatrogenic disease?
    Lurie Y; Landau DA; Blendis L; Baruch Y; Veitsman E; Ackermann Z; Zelber-Sagie S; Halpern Z; Oren R
    J Gastroenterol Hepatol; 2007 Feb; 22(2):158-64. PubMed ID: 17295865
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Current problems in the epidemiology and prevention of viral hepatitis non-A, non-B (a review of the literature)].
    Khokhlov DT; Ogarkov PI; Mal'shev VV
    Voen Med Zh; 1986 Sep; (9):38-41. PubMed ID: 3099467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.